SR ONE CAPITAL MANAGEMENT, LP

Q2 2026 13F-HR Holdings

Location
Redwood City, CA
Holdings as of
6/30/2026
Date filed
8/12/2026
Form type
13F-HR
Num holdings
15
Total value ($000)
$1,039,008
Net value change ($000)
+123,566 (13.5%)
New positions
3
Sold out positions
2
Turnover %
47.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/14/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
MANE 143,608 94.7%
Avalyn Pharma, Inc 108,921 NEW
Odyssey Therapeutics, Inc. 71,002 NEW
ZBIO 29,371 29.8%
Mobia Medical, Inc 26,613 NEW
DSGN 24,996 36.0%
CRSP 14,210 14.7%
ALMS 11,974 27.7%
NKTX 2,400 34.1%
RARE 1,714 59.4%
Top Reduces (Value $000, Stocks/ETFs)
ACLX -269,440 -100.0%
ORKA -21,108 -100.0%
ORIC -8,492 -14.5%
OCS -8,154 -47.8%
ENGN -3,798 -74.6%
MLYS -172 -0.4%
SPRY -81 -0.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type